APM

Avidity Partners Management Portfolio holdings

AUM $499M
1-Year Est. Return 3.47%
This Quarter Est. Return
1 Year Est. Return
+3.47%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$485M
AUM Growth
-$518M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
82
New
Increased
Reduced
Closed

Top Buys

1 +$13.9M
2 +$10.9M
3 +$10.8M
4
OGN icon
Organon & Co
OGN
+$7.97M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$7.62M

Top Sells

1 +$33.8M
2 +$28.2M
3 +$26.1M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$20.9M
5
KYMR icon
Kymera Therapeutics
KYMR
+$20.1M

Sector Composition

1 Healthcare 98.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVMD icon
26
Revolution Medicines
RVMD
$10.9B
$7.53M 1.44%
213,000
-233,200
TEVA icon
27
Teva Pharmaceuticals
TEVA
$23.5B
$7.39M 1.41%
+481,000
AVTR icon
28
Avantor
AVTR
$7.9B
$7.34M 1.4%
453,000
-494,000
IDYA icon
29
IDEAYA Biosciences
IDYA
$2.67B
$7.29M 1.39%
445,000
-681,700
DOCS icon
30
Doximity
DOCS
$12.3B
$7.11M 1.35%
+122,500
JANX icon
31
Janux Therapeutics
JANX
$1.62B
$6.97M 1.33%
258,000
-483,900
HQY icon
32
HealthEquity
HQY
$8.19B
$6.89M 1.31%
+78,000
BPMC
33
DELISTED
Blueprint Medicines
BPMC
$6.06M 1.16%
68,500
-108,100
UTHR icon
34
United Therapeutics
UTHR
$18.8B
$5.18M 0.99%
+16,800
PHAT icon
35
Phathom Pharmaceuticals
PHAT
$960M
$5.02M 0.96%
800,000
-590,100
IMUX icon
36
Immunic
IMUX
$68.2M
$4.86M 0.93%
4,454,408
-3,511,992
BRKR icon
37
Bruker
BRKR
$6.13B
$4.8M 0.91%
115,000
+38,700
CATX icon
38
Perspective Therapeutics
CATX
$173M
$4.68M 0.89%
2,197,270
-497,330
CNTX icon
39
Context Therapeutics
CNTX
$99.6M
$4.58M 0.87%
7,477,200
ORKA
40
Oruka Therapeutics
ORKA
$1.33B
$3.61M 0.69%
352,124
QURE icon
41
uniQure
QURE
$1.88B
$3.56M 0.68%
336,200
+114,200
BHVN icon
42
Biohaven
BHVN
$1.48B
$3.49M 0.66%
145,000
-77,900
ARVN icon
43
Arvinas
ARVN
$700M
$2.9M 0.55%
413,162
-944,838
ACAD icon
44
Acadia Pharmaceuticals
ACAD
$3.69B
$2.81M 0.54%
+169,000
RPRX icon
45
Royalty Pharma
RPRX
$16.4B
$2.71M 0.52%
+87,000
BBIO icon
46
BridgeBio Pharma
BBIO
$11.8B
$2.59M 0.49%
+75,000
KZR icon
47
Kezar Life Sciences
KZR
$44.6M
$2.45M 0.47%
502,600
AKRO icon
48
Akero Therapeutics
AKRO
$4.33B
$2.31M 0.44%
57,000
-25,000
SLNO icon
49
Soleno Therapeutics
SLNO
$3.39B
$2.29M 0.44%
+32,000
CAPR icon
50
Capricor Therapeutics
CAPR
$277M
$2.27M 0.43%
+239,000